News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tokai Pharmaceuticals, Chasing The Field In Prostate Cancer, Files For $75 Million IPO



8/12/2014 7:23:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Tokai Pharmaceuticals has been chasing after the big players in the prostate cancer field with the idea of combining some of the best features of their drugs into a single pill. Now, with that lead drug candidate, galeterone, on the precipice of a late-stage trial, it’s taking that pitch to Wall Street.

Cambridge, MA-based Tokai has filed papers outlining plans to raise up to $75 million in an IPO.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy
Read at Renaissance Capital


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES